BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 21326318)

  • 1. DNA methylation dysregulates and silences the HLA-DQ locus by altering chromatin architecture.
    Majumder P; Boss JM
    Genes Immun; 2011 Jun; 12(4):291-9. PubMed ID: 21326318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The insulator factor CTCF controls MHC class II gene expression and is required for the formation of long-distance chromatin interactions.
    Majumder P; Gomez JA; Chadwick BP; Boss JM
    J Exp Med; 2008 Apr; 205(4):785-98. PubMed ID: 18347100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The human major histocompatibility complex class II HLA-DRB1 and HLA-DQA1 genes are separated by a CTCF-binding enhancer-blocking element.
    Majumder P; Gomez JA; Boss JM
    J Biol Chem; 2006 Jul; 281(27):18435-43. PubMed ID: 16675454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of differential HLA-DQB expression in autologous B cell lines.
    Woolfrey AE; Andersen LC; Shewey L; Chung J; Nepom GT
    J Leukoc Biol; 1993 Jun; 53(6):697-706. PubMed ID: 8315353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. B cell differentiation is associated with reprogramming the CCCTC binding factor-dependent chromatin architecture of the murine MHC class II locus.
    Majumder P; Scharer CD; Choi NM; Boss JM
    J Immunol; 2014 Apr; 192(8):3925-35. PubMed ID: 24634495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A super enhancer controls expression and chromatin architecture within the MHC class II locus.
    Majumder P; Lee JT; Rahmberg AR; Kumar G; Mi T; Scharer CD; Boss JM
    J Exp Med; 2020 Feb; 217(2):. PubMed ID: 31753848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CTCF controls expression and chromatin architecture of the human major histocompatibility complex class II locus.
    Majumder P; Boss JM
    Mol Cell Biol; 2010 Sep; 30(17):4211-23. PubMed ID: 20584980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of human sepsis on CCCTC-binding factor associated monocyte transcriptional response of Major Histocompatibility Complex II components.
    Siegler BH; Uhle F; Lichtenstern C; Arens C; Bartkuhn M; Weigand MA; Weiterer S
    PLoS One; 2018; 13(9):e0204168. PubMed ID: 30212590
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cohesin regulates MHC class II genes through interactions with MHC class II insulators.
    Majumder P; Boss JM
    J Immunol; 2011 Oct; 187(8):4236-44. PubMed ID: 21911605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distinct epigenetic domains separated by a CTCF bound insulator between the tandem genes, BLU and RASSF1A.
    Chang JW; Hsu HS; Ni HJ; Chuang CT; Hsiung CH; Huang TH; Wang YC
    PLoS One; 2010 Sep; 5(9):e12847. PubMed ID: 20877461
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive Analysis of CD4
    Hyun YS; Jo HA; Lee YH; Kim SM; Baek IC; Sohn HJ; Cho HI; Kim TG
    Front Immunol; 2020; 11():602014. PubMed ID: 33658991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Significance of the expression of major histocompatibility complex class II antigen, HLA-DR and -DQ, with recurrence of papillary thyroid cancer.
    Jo YS; Lee JC; Li S; Choi YS; Bai YS; Kim YJ; Lee IS; Rha SY; Ro HK; Kim JM; Shong M
    Int J Cancer; 2008 Feb; 122(4):785-90. PubMed ID: 17957790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specific allelic variation among linked HLA class II genes.
    Amar A; Holbeck SL; Nepom GT
    Transplantation; 1987 Dec; 44(6):831-5. PubMed ID: 2892292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular analysis of HLA class I and class II antigen loss mutants reveals a homozygous deletion of the DR, DQ, and part of the DP region: implications for class II gene order.
    Erlich H; Lee JS; Petersen JW; Bugawan T; DeMars R
    Hum Immunol; 1986 Jun; 16(2):205-19. PubMed ID: 3459724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular characterization of major histocompatibility complex class II gene expression and demonstration of antigen-specific T cell response indicate a new phenotype in class II-deficient patients.
    Hauber I; Gulle H; Wolf HM; Maris M; Eggenbauer H; Eibl MM
    J Exp Med; 1995 Apr; 181(4):1411-23. PubMed ID: 7699327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Differential expression of HLA DR, DP and DQ in cultivated, human ciliary body epithelial cells].
    Helbig H; Kittredge KL; Coca-Prados M; Nussenblatt RB
    Fortschr Ophthalmol; 1991; 88(3):295-8. PubMed ID: 1889783
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetic inactivation of class II transactivator (CIITA) is associated with the absence of interferon-gamma-induced HLA-DR expression in colorectal and gastric cancer cells.
    Satoh A; Toyota M; Ikeda H; Morimoto Y; Akino K; Mita H; Suzuki H; Sasaki Y; Kanaseki T; Takamura Y; Soejima H; Urano T; Yanagihara K; Endo T; Hinoda Y; Fujita M; Hosokawa M; Sato N; Tokino T; Imai K
    Oncogene; 2004 Nov; 23(55):8876-86. PubMed ID: 15467734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Major histocompatibility complex (MHC) class II antigen (HLA-DR, DQ, and DP) expression in human fetal endocrine organs and gut.
    Oliver AM; Thomson AW; Sewell HF; Abramovich DR
    Scand J Immunol; 1988 Jun; 27(6):731-7. PubMed ID: 3293192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HLA-DR and DQ antigens in chronic lymphocytic leukemia: dissociation of expression revealed by cell surface, protein, and mRNA studies.
    Kraïba R; Loiseau P; Faille A; Poirier O; Piatier-Tonneau D; Degos L; Abita JP; Charron D
    Leukemia; 1989 May; 3(5):386-93. PubMed ID: 2497283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA methylation-independent removable insulator controls chromatin remodeling at the HOXA locus via retinoic acid signaling.
    Ishihara K; Nakamoto M; Nakao M
    Hum Mol Genet; 2016 Dec; 25(24):5383-5394. PubMed ID: 27798106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.